ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,722Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 1024

$585K Total Retail Price of All Prescriptions

Rank: 188 out of 1024

265 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Connecticut
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

9% of this provider’s 265 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 265 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 478 433 66 1 3
ATORVASTATIN CALCIUM 416 364 63 2 1
SIMVASTATIN 325 281 47 3 5
OMEPRAZOLE 254 225 41 4 9
METFORMIN HCL 233 203 30 5 10
LEVOTHYROXINE SODIUM 229 200 32 6 2
WARFARIN SODIUM 227 222* 13 7 8
LORAZEPAM 190 171 47 B 8 26
METFORMIN HCL ER 189 156 24 9 58
METOPROLOL TARTRATE 176 157 27 10 7
LISINOPRIL 175 140 29 11 4
PRAVASTATIN SODIUM 169 133 25 12 15
FUROSEMIDE 159 154* 23 13 6
HYDROCODONE-ACETAMINOPHEN 157 124 39 S3 14 32
HYDROCHLOROTHIAZIDE 135 122 20 15 11
GLIMEPIRIDE 130 107 19 16 54
ALENDRONATE SODIUM 119 114* 21 17 39
OXYCODONE-ACETAMINOPHEN 111 47 18 S2 18 61
SYNTHROID 109 93 14 19 43
DONEPEZIL HCL 106 106 13 20 25
CLOPIDOGREL 104 88 18 21 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 88 13 22 42
LOSARTAN POTASSIUM 101 76 15 23 16
MONTELUKAST SODIUM 98 78 14 24 46
BENICAR HCT 96 91* 12 25 112
ZOLPIDEM TARTRATE 95 82 19 26 19
JANUVIA 94 77 16 27 45
MIRTAZAPINE 86 86 13 28 31
METOPROLOL SUCCINATE 85 68 13 29 12
NEXIUM 84 69 16 30 33
RISPERIDONE 82 <11 <11 A 31 48
LOSARTAN-HYDROCHLOROTHIAZIDE 81 <11 <11 32 65
PIOGLITAZONE HCL 78 <11 <11 R 33 67
TAMSULOSIN HCL 77 77 13 34 24
NAMENDA 75 <11 <11 35 27
ALPRAZOLAM 75 50 13 B 35 17
VYTORIN 75 70* 13 35 173
DIOVAN 74 69* 12 38 21
PROAIR HFA 71 59 15 39 56
ESCITALOPRAM OXALATE 70 70 15 40 14
CYMBALTA 69 <11 <11 41 35
ADVAIR DISKUS 63 58* 15 42 41
CRESTOR 61 50 12 43 20
MOMETASONE FUROATE 58 44 24 44 243
QUETIAPINE FUMARATE 57 <11 <11 A 45 44
ISOSORBIDE MONONITRATE ER 56 <11 <11 46 63
ACETAMINOPHEN-CODEINE 56 56 11 S3 46 150
GABAPENTIN 55 50* 11 48 18
SERTRALINE HCL 54 <11 <11 49 23
VENTOLIN HFA 54 49* 11 49 185
POTASSIUM CHLORIDE 53 <11 <11 51 30
BENICAR 52 <11 <11 52 83
TRAZODONE HCL 50 <11 <11 53 22
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.